Atlas Trials

Switching of Sildenafil to Riociguat in CTEPH Patients

Clinical trial NCT06715280 · RECRUITING

Trial details

NCT number
NCT06715280
Sponsor
Chinese University of Hong Kong
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Thromboembolic Pulmonary Hypertension
Start date
2024-07-25
Primary completion
2026-07-22
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.